WWTR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.636200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.303400E-01
Normal-vs-Stage2
7.914800E-01
Normal-vs-Stage3
4.790000E-01
Normal-vs-Stage4
5.731800E-01
Stage1-vs-Stage2
6.116000E-01
Stage1-vs-Stage3
2.918200E-01
Stage1-vs-Stage4
3.332400E-01
Stage2-vs-Stage3
2.096800E-01
Stage2-vs-Stage4
4.041800E-01
Stage3-vs-Stage4
1.694640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.037200E-01
Normal-vs-AfricanAmerican
5.377000E-01
Normal-vs-Asian
8.473800E-01
Caucasian-vs-AfricanAmerican
1.938390E-01
Caucasian-vs-Asian
5.024000E-01
AfricanAmerican-vs-Asian
2.232000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.064000E-01
Normal-vs-Female
8.039200E-01
Male-vs-Female
6.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.958400E-01
Normal-vs-Age(41-60Yrs)
4.717200E-01
Normal-vs-Age(61-80Yrs)
9.840000E-01
Normal-vs-Age(81-100Yrs)
4.623600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.698000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.776400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.008000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.281400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.037500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.015400E-01
Normal-vs-Daily Drinker
5.751200E-01
Normal-vs-Weekly Drinker
7.956000E-01
Normal-vs-Occasional Drinker
9.211000E-01
Normal-vs-Social Drinker
5.679000E-01
Non Drinker-vs-Daily Drinker
3.494500E-02
Non Drinker-vs-Weekly Drinker
3.662400E-01
Non Drinker-vs-Occasional Drinker
4.699800E-01
Non Drinker-vs-Social Drinker
1.342800E-01
Daily Drinker-vs-Weekly Drinker
5.179900E-02
Daily Drinker-vs-Occasional Drinker
3.990400E-02
Daily Drinker-vs-Social Drinker
2.907800E-02
Weekly Drinker-vs-Occasional Drinker
7.276800E-01
Weekly Drinker-vs-Social Drinker
4.482800E-01
Occasional Drinker-vs-Social Drinker
2.815200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.676600E-01
Normal-vs-Grade 2
1.005160E-01
Normal-vs-Grade 3
1.649610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.040400E-01
Grade 1-vs-Grade 3
8.535600E-02
Grade 1-vs-Grade 4
3.676600E-01
Grade 2-vs-Grade 3
2.120600E-01
Grade 2-vs-Grade 4
1.005160E-01
Grade 3-vs-Grade 4
1.649610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.036800E-01
Normal-vs-NonDiabetic
9.644600E-01
Diabetic-vs-NonDiabetic
3.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.453600E-01
Normal-vs-NoPancreatitis
9.527800E-01
Pancreatitis-vs-NoPancreatitis
7.449000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.659400E-01
Normal-vs-N1
7.566600E-01
N0-vs-N1
3.057000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.615200E-01
Normal-vs-TP53-NonMutant
9.796000E-01
TP53-Mutant-vs-TP53-NonMutant
2.314600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
